Muciño BMC, Meneses RF, Sámano OJA, Ayar HCB, Torres ACG

Language: Spanish
References: 9
Page: 90-95
PDF size: 244.62 Kb.

ABSTRACT

Introduction: Deep brain stimulation represents a surgical alternative in patients with advanced Parkinson’s disease who present progression of motor symptoms, drug resistance or evident adverse effects with the consequent improvement in function and quality of life. Objectives: To evaluate the effect of deep brain stimulation in the subthalamic nucleus on the motor symptoms of patients with Parkinson’s disease according to section III of the pre- and postoperative UPDRS scale. Material and methods: An observational, descriptive, longitudinal, ambispective study was carried out, including 21 patients in whom a baseline preoperative evaluation was performed UPDRS OFF and a postoperative evaluation at 12 months UPDRS ON. To compare the measurements, it was used according to the distributions of the data with the Mann-Whitney-Wilcoxon U test with respect to the UPDRS, considering a statistical significance of p ‹ 0.05. Results: The average age was 64.0 ± 10.49 years, with an average symptom evolution of 8.76 ± 3.56 years. Deep brain stimulation in the subthalamic nucleus showed a reduction in motor symptoms at 12 months UPDRS ON with respect to baseline measurements UPDRS OFF 23.19 ± 16.18 vs 47.42 ± 20.82 p ‹ 0.001. Conclusions: Cerebral stimulation of both subthalamic nuclei represents an effective intervention in the surgical management of patients with Parkinson’s disease severely affected by significantly reducing motor symptoms.

REFERENCES

1. Kieburtz K. Movement disorders: neurologic principles and practice. Neurol. 1998; 50 (4): 1199. doi: 10.1212/WNL.50.4.1199.

2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55 (3): 181-184.

3. Machado A, Rezai AR, Kopell BH, Gross RE, Sharan AD, Benabid A. Deep brain stimulation for Parkinson’s disease: surgical technique and perioperative management. Mov Disord. 2006; 21 (S14): S247-S258.

4. Diagnóstico y tratamiento de la enfermedad de Parkinson inicial y avanzada en el tercer nivel de atención. México: Secretaría de Salud; 2010: 95.

5. Welter ML, Schupbach M, Czernecki V et al. Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology. 2014; 82 (15): 1352-1361.

6. Meneses-Rodríguez F, Sánchez RY, Carrasco-Vargas H, Samano-Osuna A, Jiménez-Ponce F. Clinical experience in the Hospital Central Militar with bilateral deep brain stimulation of ventro-medial globus pallidus in patients with Parkinson’s disease. Rev Med Hosp Gen Méx. 2014; 77 (4): 190-194.

7. Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014; 29 (13): 1583-1590.

8. Williams A, Gill S, Varma T et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010; 9 (6): 581-591.

9. Limousin P, Krack P, Pollak P et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998; 339 (16): 1105-1111.